gastro-congress-2018-scientifictracks

22 / 22

alliedacademies
Page 51
Journal of Gastronenterology and Digestive Diseases | Volume 3
J u n e 2 5 - 2 6 , 2 0 1 8 | D u b l i n , I r e l a n d
GASTROENTEROLOGY
International Conference on
Goodluck Fadoorn Innocent Obilor, J Gastroenterol Dig Dis 2018, Volume 3
RECENT ADVANCEMENTS AND
THERAPEUTIC TECHNIQUES IN THE
FIELD OF GASTROENTEROLOGY /
HEPATOCELLULAR CARCINOMA
(LIVER CANCER), DEVELOPING
TREATMENTS FOR VIRAL
HEPATITIS AND LIVER FIBROSIS
Goodluck Fadoorn Innocent Obilor
University of California, USA
Chemical and Pharmaceutical the author has been very useful for capturing
knowledge as in gastrointestinal diseases, hepatocellular carcinoma
(liver cancer), chemical and pharmaceutical, a prime challenge has been
taken to develop chemical and pharmaceutical function given only partial
chemical and pharmaceutical knowledge and inconsistency in how this
knowledge is curated by experts, again towards a data-driven gene ontology,
clinical nutrition in gastrointestinal diseases, probiotics as gastrointestinal
therapeutics, advancements and current research in gastrointestinal
therapeutics, GI oncology, ontologies have been very useful for capturing
knowledge as a hierarchy of concepts and their interrelationships. In biology,
a prime challenge has been to develop ontologies of gene function given
only partial biological knowledge and inconsistency in how this knowledge is
curated by experts. The author will discuss how large networks of gene and
protein interaction, as are being mapped systematically for many species,
can be transformed to assemble an ontology with equivalent coverage and
power to the manually-curated gene ontology (GO). Our network-extracted
ontology contains 4,123 biological concepts.
Goodluck Fadoorn Innocent Obilor, PhD. is Pro-
fessor of Medicine at the University of Califor-
nia at San Diego. He serves as Division Chief of
Medical Genetics and Director of the National
Resource for Network Biology, as well as be-
ing Adjunct Professor of Bioengineering and
Computer Science and Member of the Moors
UCSD Cancer Center. He received bachelor’s
and master’s degrees fromMIT in Chemical and
Pharmaceutical Engineering his Ph.D. from the
University of Washington in Molecular Biology
under the supervision of Dr. Leroy Hood. He is a
pioneer in assembling genome-scale measure-
ments to construct Chemical and Pharmaceuti-
cal processes and disease. His recent research
activities include assembly of networks govern-
ing the response to DNA damage; development
of the Cystoscope and Network BLAST soft-
ware packages for biological network visual-
ization and cross-species network comparison;
and methods for identifying network-based bio-
markers in development and disease. Fa doorn
serves on the Editorial Boards for Bioinformat-
ics, Chemical and Pharmaceutical, is on the Sci-
entific Advisory Boards of the Sanford-Burnham
Medical Research Institute and the Institute for
Systems Biology and is a regular consultant for
companies such as Monsanto and Mendel Bio-
technology. He was named one of the Top 10
Innovators of 2006 by Technology Review mag-
azine and was the recipient of the 2009 Overton
Prize from the International Society for Com-
putational Biology. His work has been featured
in news outlets such as The Scientist, the San
Diego Union Tribune, Forbes magazine and the
New York Times.
BIOGRAPHY